Arax Advisory Partners’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$88.2K Sell
1,103
-16
-1% -$1.28K ﹤0.01% 987
2025
Q1
$81.1K Sell
1,119
-583
-34% -$42.3K 0.01% 788
2024
Q4
$126K Buy
1,702
+724
+74% +$53.6K 0.01% 605
2024
Q3
$64.5K Buy
978
+99
+11% +$6.53K 0.01% 623
2024
Q2
$81.2K Buy
879
+244
+38% +$22.5K 0.01% 514
2024
Q1
$60.7K Buy
635
+10
+2% +$956 0.01% 459
2023
Q4
$47.7K Sell
625
-11
-2% -$839 0.01% 487
2023
Q3
$44.1K Buy
636
+474
+293% +$32.8K 0.01% 482
2023
Q2
$15.3K Buy
162
+7
+5% +$660 ﹤0.01% 630
2023
Q1
$12.8K Sell
155
-8
-5% -$662 ﹤0.01% 651
2022
Q4
$12.2K Sell
163
-310
-66% -$23.1K ﹤0.01% 622
2022
Q3
$39K Buy
473
+1
+0.2% +$82 0.01% 465
2022
Q2
$45K Buy
472
+24
+5% +$2.29K 0.01% 440
2022
Q1
$53K Sell
448
-27
-6% -$3.19K 0.01% 443
2021
Q4
$62K Hold
475
0.01% 432
2021
Q3
$54K Sell
475
-58
-11% -$6.59K 0.01% 442
2021
Q2
$55K Buy
+533
New +$55K 0.01% 449
2020
Q4
$49K Hold
540
0.01% 415
2020
Q3
$43K Sell
540
-160
-23% -$12.7K 0.01% 399
2020
Q2
$48K Sell
700
-2,000
-74% -$137K 0.01% 373
2020
Q1
$170K Hold
2,700
0.04% 167
2019
Q4
$210K Hold
2,700
0.06% 151
2019
Q3
$198K Hold
2,700
0.06% 155
2019
Q2
$166K Buy
+2,700
New +$166K 0.06% 164
2018
Q4
$245K Buy
4,803
+2,799
+140% +$143K 0.1% 105
2018
Q3
$116K Buy
2,004
+1,524
+318% +$88.2K 0.05% 179
2018
Q2
$23K Buy
480
+138
+40% +$6.61K 0.01% 284
2018
Q1
$15K Sell
342
-75
-18% -$3.29K 0.01% 295
2017
Q4
$15K Hold
417
0.01% 299
2017
Q3
$15K Buy
417
+15
+4% +$540 0.01% 296
2017
Q2
$16K Hold
402
0.01% 316
2017
Q1
$12K Hold
402
0.01% 314
2016
Q4
$13K Buy
+402
New +$13K 0.01% 296